Ribomic Inc. provided non-consolidated earnings guidance for the full year ending March 31, 2021. For the period, the company expects operating revenue to be JPY 118 million. Operating loss is expected to be JPY 1,561 million. Loss is expected to be JPY 1,485 million. Loss per share is expected to be JPY 84.61.